Fleming Ingrid
Vascular Signalling Group, Institut für Kardiovaskuläre Physiologie, Johann Wolfgang Goethe-Universität, Theodor-Stern-Kai 7, Germany.
Trends Pharmacol Sci. 2007 Sep;28(9):448-52. doi: 10.1016/j.tips.2007.08.002. Epub 2007 Aug 30.
Cytochrome P450 (CYP)-derived epoxyeicosatrienoic acids (EETs) are lipid signalling molecules that elicit vasodilatation and modulate various intracellular signalling cascades. The generation of EETs by epoxygenases expressed in the vascular endothelium has been linked with endothelial cell proliferation, migration and angiogenesis. The EETs also possess anti-inflammatory properties and can attenuate monocyte infiltration. Although an increase in CYP epoxygenase expression or activity should theoretically be beneficial, many of these enzymes generate reactive oxygen species which in themselves are pro-inflammatory and promote processes that functionally antagonize those of the EETs. There is potential for selecting the anti-inflammatory actions of the EETs by preventing their metabolism by the soluble epoxide hydrolase.
细胞色素P450(CYP)衍生的环氧二十碳三烯酸(EETs)是一类脂质信号分子,可引起血管舒张并调节各种细胞内信号级联反应。血管内皮中表达的环氧酶生成EETs与内皮细胞增殖、迁移和血管生成有关。EETs还具有抗炎特性,可减弱单核细胞浸润。虽然理论上CYP环氧酶表达或活性增加应是有益的,但这些酶中的许多会产生活性氧,而活性氧本身具有促炎作用,并促进与EETs功能相拮抗的过程。通过阻止可溶性环氧化物水解酶对EETs的代谢,有可能选择发挥EETs的抗炎作用。